Src inhibition is still a relevant target in pancreatic cancer

about

Elucidation of the roles of the Src kinases in pancreatic acinar cell signaling A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

P2860

Q34498518-2F70FB7E-214C-40B1-98C9-F1808EDB360D Q35875878-B4D906B9-7092-47A6-89CF-04163D7C3187 Q36657755-6B4918EF-EEF6-43B7-B8CA-4681FC298E1F

P2860

Src inhibition is still a relevant target in pancreatic cancer

Item

http://www.wikidata.org/entity/Q42507019

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Src inhibition is still a relevant target in pancreatic cancer

@en

Src inhibition is still a relevant target in pancreatic cancer

@nl

type

Item

label

Src inhibition is still a relevant target in pancreatic cancer

@en

Src inhibition is still a relevant target in pancreatic cancer

@nl

prefLabel

Src inhibition is still a relevant target in pancreatic cancer

@en

Src inhibition is still a relevant target in pancreatic cancer

@nl

P1476

Src inhibition is still a relevant target in pancreatic cancer

@en

P2093

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Jose G Trevino

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.

Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.

Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.

Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis.

Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.

Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.

Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.

Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.

P304

211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2013-0410

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas J George

P577

2014-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259881759

http://www.w3.org/2001/XMLSchema#string

P698

24457377

http://www.w3.org/2001/XMLSchema#string

P932

3926798

http://www.w3.org/2001/XMLSchema#string

Src inhibition is still a relevant target in pancreatic cancer

about

P2860

P2860

Src inhibition is still a relevant target in pancreatic cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932